Phylogica Signs Agreement with MedImmune / AstraZeneca
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Phylogica - New Potential For Treating Brain Injury
- Phylogica Accesses Novel Half-Life Extension Technology
- Technology Licence to Janssen Biotech
- Share Placement raises $2.15 Million
- Pfizer First Stage of Collaboration Complete
Later from PYC Therapeutics
- R&D Tax Rebate
- Cell-Penetrating Phylomers Improve Delivery of Drugs
- Chief Executive Officer Resignation
- Operational Update
- Shareholder Update
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics